Agreement opens new pathways for Lithuanian life science scale-ups
Innovation Agency Lithuania and AstraZeneca BioVentureHub (BVH) have signed a Memorandum of Understanding (MoU) at the Life Sciences Baltics 2025 event.
The agreement establishes a framework for collaboration aimed at assisting Lithuanian life science companies in engaging with BVH’s open innovation community in Gothenburg.
It will also help them connect with world-class expertise, infrastructure, and networks.
Housed at AstraZeneca’s R&D site in Gothenburg, Sweden, BioVentureHub provides an open innovation environment where emerging life-science and health-tech companies work alongside experienced scientists and industry professionals.
The Hub’s community and partner programmes foster collaboration, knowledge-sharing, and faster progress from idea to impact – with alumni and residents including companies such as OnDosis, NordicRWE and Antaros Medical.
Under this collaboration framework, Lithuanian life-science SMEs will be able to explore opportunities to engage with the BVH community – gaining proximity to scientific know-how, exposure to industrial best practice, and access to state-of-the-art laboratories and facilities.
The initiative is expected to help high-potential ventures navigate critical steps from laboratory research to pilot-scale development, build international partnerships, and connect more directly to global pharma and biotech value chains.
“By connecting Lithuanian scale-ups to our open innovation ecosystem, we aim to accelerate knowledge-sharing and foster new avenues for scientific exploration. This partnership demonstrates what can be achieved when scientific curiosity meets diverse expertise – and we look forward to seeing the outcomes of these connections, from early discovery through to real-world application,” said Ulrika Edvardsson, Managing Director of AstraZeneca BioVentureHub.
“Lithuania’s life-science entrepreneurs are building bold, data-driven innovations. By creating a clear bridge into AstraZeneca BioVentureHub’s community and infrastructure, we’re helping them learn faster, collaborate smarter and scale with confidence,” added Jekaterina Kalinienė, Head of BioTech Lab at Innovation Agency Lithuania. “This collaboration brings our ecosystems closer together and gives Lithuanian teams a pathway from the lab bench to real-world impact.”
